Table of Contents
The Market for Prenatal, Newborn and Carrier Genetic Testing provides the world markets for prenatal, newborn, postnatal, and carrier genetic testing for 2014 to 2019. In addition, company revenues are provided for the previous three years. Further, this report includes financial information on deals involving companies in the molecular diagnostic inherited disease/prenatal testing field, summarized within report tables.
Prenatal testing can be used to identify fetuses with chromosomal abnormalities or genetic mutations that would result in the birth of an affected newborn. Women who are experience recurrent miscarriages can be tested to determine if there is a genetic cause, if their fetuses could not survive due to an inherited disorder. Children may also be tested, often to identify the cause of developmental or intellectual delay. These and other applications of inherited disease testing are discussed in the report.
The report also discusses
Genetic Testing Services Market
Get Industry Insights. Simply.
Talk to Amrita
+1 718 303 2019
The global non-invasive prenatal testing (NIPT) market is projected to reach USD 2.88 billion by 2021 from USD 1.35 billion in 2016, at a CAGR of 16.4% from 2016 to 2021. The major factors driving the ...
“Genomic Discoveries and Direct to Consumer Drive Growth in a New Genetic Testing Industry....” Will all newborns receive Whole Genomic Sequencing at birth? How fast will Direct to Consumer Testing ...
This report analyzes the worldwide markets for Direct-to-Consumer (DTC) Genetic Testing in US$ Thousand. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, ...